116 related articles for article (PubMed ID: 30182347)
1. Cardiovascular disease in chronic myelomonocytic leukemia: do monocytosis and chronic inflammation predispose to accelerated atherosclerosis?
Elbæk MV; Sørensen AL; Hasselbalch HC
Ann Hematol; 2019 Jan; 98(1):101-109. PubMed ID: 30182347
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of monocytosis in patients with myeloproliferative disorders.
Beran M; Shen Y; Onida F; Wen S; Kantarjian H; Estey E
Leuk Lymphoma; 2006 Mar; 47(3):417-23. PubMed ID: 16396764
[TBL] [Abstract][Full Text] [Related]
3. Hematopoietic progenitor cell colony growth differentiates chronic myelomonocytic leukemia from reactive monocytosis.
Birrer A; Jusufi F; Bernimoulin M; Tichelli A; Gratwohl A; Nissen-Druey C; Dirnhofer S; Meyer-Monard S; Stern M
Eur J Haematol; 2008 Oct; 81(4):267-72. PubMed ID: 18616511
[TBL] [Abstract][Full Text] [Related]
4. The use of medical claims to assess incidence, diagnostic procedures and initial treatment of myelodysplastic syndromes and chronic myelomonocytic leukemia in the Netherlands.
Dinmohamed AG; van Norden Y; Visser O; Posthuma EF; Huijgens PC; Sonneveld P; van de Loosdrecht AA; Jongen-Lavrencic M
Leuk Res; 2015 Feb; 39(2):177-82. PubMed ID: 25533930
[TBL] [Abstract][Full Text] [Related]
5. Therapy for Chronic Myelomonocytic Leukemia in a New Era.
Moyo TK; Savona MR
Curr Hematol Malig Rep; 2017 Oct; 12(5):468-477. PubMed ID: 28983777
[TBL] [Abstract][Full Text] [Related]
6. The 2016 WHO versus 2008 WHO Criteria for the Diagnosis of Chronic Myelomonocytic Leukemia.
Moon Y; Kim MH; Kim HR; Ahn JY; Huh J; Huh JY; Han JH; Park JS; Cho SR
Ann Lab Med; 2018 Sep; 38(5):481-483. PubMed ID: 29797820
[TBL] [Abstract][Full Text] [Related]
7. Chronic inflammation and autoimmunity as risk factors for the development of chronic myelomonocytic leukemia?
Elbæk MV; Sørensen AL; Hasselbalch HC
Leuk Lymphoma; 2016 Aug; 57(8):1793-9. PubMed ID: 26879691
[TBL] [Abstract][Full Text] [Related]
8. Chronic myelomonocytic leukemia with nucleophosmin (NPM1) mutation.
Peng J; Zuo Z; Fu B; Oki Y; Tang G; Goswami M; Priyanka P; Muzzafar T; Medeiros LJ; Luthra R; Wang SA
Eur J Haematol; 2016 Jan; 96(1):65-71. PubMed ID: 25809997
[TBL] [Abstract][Full Text] [Related]
9. Application of immunophenotypic analysis in distinguishing chronic myelomonocytic leukemia from reactive monocytosis.
Feng R; Bhatt VR; Fu K; Pirruccello S; Yuan J
Cytometry B Clin Cytom; 2018 Nov; 94(6):901-909. PubMed ID: 30334354
[TBL] [Abstract][Full Text] [Related]
10. A close association of autoimmune-mediated processes and autoimmune disorders with chronic myelomonocytic leukemia: observation from a single institution.
Peker D; Padron E; Bennett JM; Zhang X; Horna P; Epling-Burnette PK; Lancet JE; Pinilla-Ibarz J; Moscinski L; List AF; Komrokji RS; Zhang L
Acta Haematol; 2015; 133(2):249-56. PubMed ID: 25413011
[TBL] [Abstract][Full Text] [Related]
11. Chronic myelomonocytic leukaemia (CMML)--a myelodysplastic or myeloproliferative syndrome?
Michaux JL; Martiat P
Leuk Lymphoma; 1993 Jan; 9(1-2):35-41. PubMed ID: 8477199
[TBL] [Abstract][Full Text] [Related]
12. Cytopenia, dysplasia, and monocytosis: a precursor to chronic myelomonocytic leukemia or a distinct subgroup? Case reports and review of literature.
Singh ZN; Post GR; Kiwan E; Maddox AM
Clin Lymphoma Myeloma Leuk; 2011 Jun; 11(3):293-7. PubMed ID: 21658659
[TBL] [Abstract][Full Text] [Related]
13. Analyses on clinical characteristic and prognoses of 41 patients with chronic myelomonocytic leukemia in China.
Chen B; Ma Y; Xu X; Wang X; Qin W; Ji M; Lin G
Leuk Res; 2010 Apr; 34(4):458-62. PubMed ID: 19631982
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Azacitidine in autoimmune and inflammatory disorders associated with myelodysplastic syndromes and chronic myelomonocytic leukemia.
Fraison JB; Mekinian A; Grignano E; Kahn JE; Arlet JB; Decaux O; Denis G; Buchdahl AL; Omouri M; Maigne G; Aouba A; Leon N; Berthier S; Liozon E; Park S; Gardin C; Lortholary O; Rossignol J; Fenaux P; Fain O; Braun T
Leuk Res; 2016 Apr; 43():13-7. PubMed ID: 26922775
[TBL] [Abstract][Full Text] [Related]
15. Atypical chronic myeloid leukaemia with trisomy 21 mosaicism as a sole chromosomal abnormality.
Benedek D; Kiehl M; Draube A; Chemnitz J; Diehl V; Söhngen D
Leuk Lymphoma; 2000 Aug; 38(5-6):639-44. PubMed ID: 10953987
[TBL] [Abstract][Full Text] [Related]
16. 3q26/EVI1 rearrangement in myelodysplastic/myeloproliferative neoplasms: An early event associated with a poor prognosis.
Hu Z; Hu S; Ji C; Tang Z; Thakral B; Loghavi S; Medeiros LJ; Wang W
Leuk Res; 2018 Feb; 65():25-28. PubMed ID: 29288910
[TBL] [Abstract][Full Text] [Related]
17. Chronic myelomonocytic leukemia monocytes uniformly display a population of monocytes with CD11c underexpression.
Sojitra P; Gandhi P; Fitting P; Kini AR; Alkan S; Velankar MM; Venkataraman G
Am J Clin Pathol; 2013 Nov; 140(5):686-92. PubMed ID: 24124148
[TBL] [Abstract][Full Text] [Related]
18. The detection of SRSF2 mutations in routinely processed bone marrow biopsies is useful in the diagnosis of chronic myelomonocytic leukemia.
Federmann B; Abele M; Rosero Cuesta DS; Vogel W; Boiocchi L; Kanz L; Quintanilla-Martinez L; Orazi A; Bonzheim I; Fend F
Hum Pathol; 2014 Dec; 45(12):2471-9. PubMed ID: 25305095
[TBL] [Abstract][Full Text] [Related]
19. RAS mutations contribute to evolution of chronic myelomonocytic leukemia to the proliferative variant.
Ricci C; Fermo E; Corti S; Molteni M; Faricciotti A; Cortelezzi A; Lambertenghi Deliliers G; Beran M; Onida F
Clin Cancer Res; 2010 Apr; 16(8):2246-56. PubMed ID: 20371679
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia.
Mittal P; Saliba RM; Giralt SA; Shahjahan M; Cohen AI; Karandish S; Onida F; Beran M; Champlin RE; de Lima M
Bone Marrow Transplant; 2004 May; 33(10):1005-9. PubMed ID: 15048141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
